Creative Biolabs has conducted extensive and in-depth research on the MERS epidemic in 2012, and has contributed a lot to the research and control of coronavirus pneumonia, and thus has accumulated a lot of experience. Therefore, at the end of 2019, when a new type of coronavirus pneumonia (which is officially named by the WHO as coronavirus disease 2019, abbreviated "COVID-19" on Feb 11, 2020) broke out in Wuhan, China, Creative Biolabs quickly organized relevant researchers, and set up a dedicated research team to carry out intensive analysis and research on the SARS-COV2 virus (formerly known as 2019-nCoV). The team has rapidly developed related proteins, antibodies, nucleic acid extraction kits and other products to help researchers quickly develop effective anti-COVID-19 drugs and vaccines. Relying on our mature drug development and vaccine development technology and experience, we also provide researchers with excellent CRO services regarding to discovery services of anti-SARS-COV2 (COVID-19, 2019-nCoV) drugs as well as vaccine development services, preclinical research services, various in vivo and in vivo research models, and in vivo diagnostic immunoassay services.

Comprehensive COVID-19/ SARS-COV2/ 2019-nCoV Research Tools and Services

Creative Biolabs is the leading custom service provider that has extensive experience in various antibody production and engineering fields. Our service portfolio includes mouse and rat monoclonal antibody production using hybridoma technology, human, monkey, rabbit, chicken, dog, llama and camel monoclonal antibody production using various antibody library technologies (including phage display, bacterial display and yeast display). We are also professional in conducting in-depth antibody humanization and affinity maturation using phage display and DNA mutagenesis approaches. In addition, OEM services for bulk scale antibody manufacturing, including bacterial production of scFv, diabody, tandem scFv, miniantibody and Fab, and mammalian cell expression of minibody, chimeric IgG, and IgG, are also available at the most competitive price in the industry.

The Flow Cytometry Core Facility at LFKRI/New York Blood Center provides in-house investigators and external clients with state-of-the-art-equipment for multiparameter flow cytometric analysis and cell sorting. The Core provides training and expert assistance with various techniques in flow cytometry/cell sorting as well as consultation in experimental design, data analysis, presentation, and publication.

PostGIS; http://postgis.net/
Spatial and Geographic objects for PostgreSQL

Our laboratory houses an array of cutting-edge liquid chromatography and gas chromatography mass spectrometry instrumentation. This equipment enables selective identification and reproducible quantification of trace-level biomolecules in complex samples. In particular, we offer label-free protein quantitation using SWATH-MS approach as a complete service that includes sample preparation, data acquisition and data analysis.